Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHK-Cu

Copper Tripeptide-1, Glycyl-L-Histidyl-L-Lysine Copper, Prezatide Copper

Quick Stats
Studies 149
Trials 1
Score 3
2024 pubmed 2 citations

Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.

Mortazavi. Seyedeh Maryam SM; Mohammadi Vadoud. Seyyed Ali SA; Moghimi. Hamid Reza HR

Key Findings

  • GHK stimulates collagen, glycosaminoglycan production, nerve growth, and new blood vessels, which are all good for skin health.
  • Metal‑complexed (GHK‑Cu) and palmitoylated (Pal‑GHK) forms are more skin‑permeable than plain GHK, but still limited.
  • No clinical trials have tested GHK‑Cu or Pal‑GHK on human skin for wrinkle reduction.
  • Permeation enhancers such as cell‑penetrating peptides, microneedle pretreatment, or other chemical enhancers can improve delivery.
  • Formulating these peptides is challenging because they are very water‑soluble, have low oil affinity, and can degrade easily.

Practical Outcomes

  • If you want to try GHK topically, pick products that use the copper‑bound or palmitoylated version and look for added penetration enhancers (e.g., microneedle rollers, CPPs, or approved chemical enhancers). Expect modest benefits and be aware that scientific proof in humans is still scarce, so monitor your skin response and store the product to minimize degradation.

Summary

GHK is a tiny peptide that can boost collagen, help skin heal, and may reduce wrinkles, but the versions used in creams (GHK‑Cu and Pal‑GHK) don’t get into the skin very well on their own. Adding a copper atom or a fatty tail makes them a bit more skin‑friendly, and tricks like cell‑penetrating tags or microneedle rollers can push them deeper. However, there are hardly any real‑world human studies proving they work, and the peptides can be unstable in formulas.

Abstract

Peptides are promising and attractive anti-wrinkle active ingredients, amongst which glycyl-histidyl-lysine peptide (GHK) is one of the most broadly promoted peptide for topical application. This simple sequence of amino acid residues not only has the capability of tissue regeneration and the enhancement of collagen and glycosaminoglycans synthesis but also is able to increase nerve outgrowth and angiogenesis. Consequently, GHK has several properties, from wound healing to prevention/reduction wrinkles. GHK-Cu and Pal-GHK are metal complex and palmitoylated derivatives of GHK, respectively. Although GHK-Cu and Pal-GHK are widely used in anti-wrinkle products available on the cosmetic market, the published information on their skin permeability, effectiveness, physicochemical properties and so on is insufficient. This review aims to highlight whether GHK is sufficiently effective on wrinkle prevention/reduction. Apart from the effectiveness, another question that is tried to be answered is whether skin permeability of GHK allows it to act as an anti-wrinkle peptide at its site of action? Skin permeation enhancement methods employed so far are also reviewed. Based on cellular studies, undoubtedly, GHK can be considered as an anti-wrinkle ingredient. Although GHK-Cu and Pal-GHK have been of interest as effective peptides to be incorporated in the anti-wrinkle products, there is a surprising absence of clinical studies using them. Metal complexation and chemical modification with a hydrophobic moiety increase permeability of this peptide. Besides, cell penetrating peptides seem promising to increase skin permeation of GHK and its derivatives. Skin pretreatment with microneedles also has the potential to be further studied for permeation enhancement of such peptides. As peptide ingredients, their formulation may encounter some challenges, mainly due to their hydrophilic (high aqueous solubility and low partition coefficient) and unstable nature. Although GHK-Cu and Pal-GHK are effective and relatively skin permeable, their permeability could be successfully increased using permeation enhancement methodologies.

Study Information

Provider

pubmed

Year

2024

Date

2024-04-28T00:00:00.000Z

DOI

10.34172/bi.30071

Citations

2

References

45